二陈汤对血脂异常痰浊阻遏证小鼠PHGDH甲基化及其介导的丝氨酸代谢信号通路的影响OA
Effects of Erchen Decoction on PHGDH methylation and the PHGDH-mediated serine metabolism signaling pathway in mice with dyslipidemia of the phlegm-dampness obstruction syndrome
目的 观察二陈汤对血脂异常痰浊阻遏证小鼠3-磷酸甘油酸脱氢酶(PHGDH)甲基化及其介导的丝氨酸代谢信号通路的影响.方法 将C57BL/6J小鼠作为正常组,取ApoE基因敲除小鼠20只制备血脂异常痰浊阻遏证模型,取5只制备血脂异常脾肾阳虚证模型.造模成功后,用随机数字表法将ApoE基因敲除小鼠分为模型组、方证相应低剂量组、方证相应中剂量组、方证相应高剂量组、方证不相应组,每组各5只.方证相应低、中、高剂量组分别给予二陈汤4.45、8.90、17.8 g/(kg·d)灌胃;方证不相应组给予二陈汤8.90 g/(kg·d)灌胃;正常组、模型组给予相同体积的生理盐水灌胃.均每天灌胃1次,共4周.用酶联免疫吸附试验(ELISA)检测血清PHGDH水平,甲基化敏感限制性内切酶聚合酶链反应(MSRE-PCR)检测主动脉PHGDH基因甲基化水平,逆转录定量聚合酶链反应(RT-PCR)检测主动脉PHGDH mRNA表达水平,液相色谱-质谱联用(LC-MS)法检测血清丝氨酸代谢通路关键代谢物水平.结果 与正常组比较,模型组小鼠PHGDH基因甲基化水平高,PHGDH mRNA表达、血清PHGDH水平低(P<0.05);与模型组比较,方证相应中剂量组PHGDH基因甲基化水平低,PHGDH mRNA表达、血清PHGDH水平、丝氨酸、苏氨酸水平高(P<0.05);与方证相应中剂量组比较,方证不相应组PHGDH基因甲基化水平高,PHGDH mRNA表达、血清PHGDH水平、丝氨酸、苏氨酸水平低(P<0.05).结论 二陈汤可抑制血脂异常痰浊阻遏证小鼠主动脉PHGDH基因甲基化,从而提高PHGDH基因表达水平,降低氧化应激,激活丝氨酸代谢通路.
Objective To investigate the effects of Erchen Decoction on 3-phosphoglycerate dehydrogenase(PHGDH)methylation and the PHGDH-mediated serine metabolism signaling pathway in mice with dyslipidemia phlegm-dampness obstruction syndrome.Methods C57BL/6J mice were used as the normal group.Twenty ApoE knockout mice were selected using a random number table method to establish a model of dyslipidemia with phlegm-dampness obstruction syndrome,and five ApoE knockout mice were used to establish a model of dyslipidemia with spleen-kidney yang deficiency syndrome.After successful modeling,the ApoE knockout mice were randomly divided into a model group,a prescription-syndrome corresponding low-dose group,a prescription-syndrome corresponding medium-dose group,a prescription-syndrome corresponding high-dose group,and a prescription-syndrome non-corresponding group,with 5 mice in each group.The prescription-syndrome corresponding low-,medium-,and high-dose groups were administered Erchen Decoction by gavage at doses of 4.45,8.90,and 17.8 g/(kg·d),respectively.The prescription-syndrome non-corresponding group received Erchen Decoction at 8.90 g/(kg·d).The normal and model groups were given an equal volume of normal saline by gavage.All groups were treated once daily for 4 weeks.Serum PHGDH levels were measured by enzyme-linked immunosorbent assay(ELISA).The methylation level of the PHGDH gene in aortic tissue was determined by methylation-sensitive restriction endonuclease polymerase chain reaction(MSRE-PCR).The mRNA expression level of PHGDH in aortic tissue was measured by reverse transcription polymerase chain reaction(RT-PCR).Serum levels of key metabolites in the serine metabolism pathway were detected by liquid chromatography-mass spectrometry(LC-MS).Results Compared with the normal group,the model group showed higher methylation levels of the PHGDH gene and lower PHGDH mRNA expression and serum PHGDH levels(P<0.05).Compared with the model group,the prescription-syndrome corresponding medium-dose group showed lower PHGDH gene methylation levels and higher PHGDH mRNA expression,serum PHGDH levels,and levels of serine and threonine(P<0.05).Compared with the prescription-syndrome corresponding medium-dose group,the prescription-syndrome non-corresponding group showed higher PHGDH gene methylation levels and lower PHGDH mRNA expression,serum PHGDH levels,and levels of serine and threonine(P<0.05).Conclusion Erchen Decoction can inhibit PHGDH gene methylation in the aorta of mice with dyslipidemia phlegm-dampness obstruction syndrome,thereby upregulating PHGDH gene expression,reducing oxidative stress,and activating the serine metabolism pathway.
陈心怡;薛晓琳;叶超;杨正;赵久丽;李鹏洋;张晓栋;陈鹏宇;陈婧
北京中医药大学中医学院,北京 102401北京中医药大学中医学院,北京 102401北京中医药大学东直门医院骨伤科,北京 100700北京中医药大学国家中医体质与治未病研究院,北京 102401北京中医药大学东直门医院骨伤科,北京 100700北京中医药大学东直门医院骨伤科,北京 100700北京中医药大学中医学院,北京 102401北京中医药大学中医学院,北京 102401北京中医药大学第三附属医院治未病中心,北京 100029
二陈汤血脂异常痰浊阻遏证3-磷酸甘油酸脱氢酶丝氨酸代谢通路氧化应激血管内皮损伤
Erchen Decoctiondyslipidemiaphlegm-dampness obstruction syndromePHGDHserine metabolism pathwayoxidative stressvascular endothelial injury
《北京中医药》 2026 (2)
190-195,6
北京市自然科学基金面上项目(7242233)国家自然科学基金青年科学基金项目(82004237)北京中医药大学中央高校基本科研业务费(揭榜挂帅)项目(2023-JYB-JBQN-044)北京中医药大学第三附属医院精诚人才(精诚青苗)项目(2025-QNKY-002)北京中医药新时代125工程培训项目(京中医药科字[2025]2号)北京高层次创新创业人才支持计划(春蕾)项目(G202534231)中央高水平中医医院临床科研业务费项目(DZMG-ZLZX-25021)
评论